Eli Lilly and Company (LLY)
NYSE · Healthcare
Eli Lilly and Company EPS 2020–2025
Eli Lilly and Company annual/quarterly eps history and growth rate from 2020 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Eli Lilly and Company eps for the quarter ending March 31, 2026 was $8.26, a 169.93% increase year-over-year.
- Eli Lilly and Company annual eps for 2025 was $22.95, a 95.99% increase from 2024.
- Eli Lilly and Company annual eps for 2024 was $11.71, a 101.90% increase from 2023.
- Eli Lilly and Company annual eps for 2023 was $5.80, a 11.75% decrease from 2022.
- Eli Lilly and Company annual eps for 2022 was $6.57.
EPS
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Eli Lilly and Company EPS — FAQ
Eli Lilly and Company (LLY) eps over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Eli Lilly and Company's eps?
Eli Lilly and Company (LLY) reported eps of $22.95 for fiscal 2025.
Where can I see LLY's eps history?
The chart and table above show Eli Lilly and Company's eps by year and by quarter, including the growth rate.